Key result
In patients with nonalcoholic fatty liver disease and obesity, bariatric surgery was associated with a significantly reduced risk of new-onset heart failure (HR 0.61) and composite cardiovascular events compared to no surgery.
Why the study?
To evaluate the methodological limitations, unaddressed confounding factors, and potential biases in research assessing the relationship between cardiovascular health metrics and MAFLD.
Does bariatric surgery reduce cardiovascular events and mortality in patients with nonalcoholic fatty liver disease and obesity?
Cohort (n=9,374)
Yes
Does bariatric surgery reduce cardiovascular events and mortality in patients with nonalcoholic fatty liver disease and obesity?
Bariatric surgery in patients with obesity and NAFLD is associated with a significant reduction in long-term cardiovascular events and all-cause mortality.
CVH metrics associate with MAFLD prevalence; leaves open causality and practice implications.
investigated the relationship between CVH metrics, specifically Life's Simple 7 and Life's Essential 8, and the prevalence of MAFLD. While this study offered important insights into the relationship between CVH and MAFLD, several methodological limitations, unaddressed confounding factors, and potential biases that could impact the interpretation of their findings should be considered. The study's cross-sectional nature restricted the ability to draw causal conclusions, and it did not fully account for potential confounding factors such as dietary habits, genetic predispositions, and medication use. Furthermore, relying on transient elastography to diagnose MAFLD introduces certain diagnostic limitations. Longitudinal study designs, advanced statistical modeling techniques, and diverse population groups should be utilized to strengthen future research. Exploring the mechanistic pathways that link CVH metrics to MAFLD through multi-omics approaches and interventional studies will be essential in formulating targeted prevention and treatment strategies. Structural equation modeling and machine learning techniques could provide a more refined analysis of these interrelated factors. Additionally, future research should employ longitudinal study designs and explore genetic and epigenetic influences to enhance our understanding of CVH and MAFLD interactions.
No takes yet. Share an insight, caveat, or question.
Krishnan et al. (2025) conducted a cohort in Nonalcoholic fatty liver disease (NAFLD) and obesity (n=9,374). Bariatric surgery vs. No bariatric surgery was evaluated on New-onset heart failure (at 7 years, excluding 1 year from index date) (HR 0.61, 95% CI 0.50-0.75). In patients with nonalcoholic fatty liver disease and obesity, bariatric surgery was associated with a significantly reduced risk of new-onset heart failure (HR 0.61) and composite cardiovascular events compared to no surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: